Literature DB >> 1479624

Mitochondrial abnormalities in myocardium of dogs with chronic heart failure.

H N Sabbah1, V Sharov, J M Riddle, T Kono, M Lesch, S Goldstein.   

Abstract

The number, size and structural integrity of mitochondria (MIT) were evaluated in the myocardium of 12 dogs with chronic heart failure (CHF) produced by sequential intracoronary microembolizations (EMB). Tissue specimens for transmission electron microscopy were obtained from the left ventricular (LV) free wall, septum and right ventricular free wall 3 to 4 months after the last EMB. Comparisons were made with samples obtained from identical sites in 9 control dogs. In dogs with CHF, LV ejection fraction decreased from 61 +/- 1% at baseline (prior to EMB) to 22 +/- 2% 3 to 4 months after the last EMB (P < 0.01) while plasma norepinephrine (PNE) concentration increased from 364 +/- 12 pg/ml to 837 +/- 150 pg/ml (P < 0.01). The number of MIT in an area of 100 square sarcomeres was greater in CHF dogs compared to controls (92 +/- 5 vs 64 +/- 2) (P < 0.001); whereas the average size of MIT was smaller (0.53 +/- 0.03 vs. 0.78 +/- 0.04 microm2) (P < 0.001). Injury ranging in severity from matrix depletion to myelinization and membrane disruption was present in 27 +/- 4% of MIT of CHF dogs compared to only 3 +/- 1% of MIT of controls (P < 0.001). MIT abnormalities were present to the same extent in all three regions of the heart. The severity of MIT injury, assessed on the basis of an injury index, was significantly higher in CHF dogs with PNE > or = 600 pg/ml (0.64 +/- 0.07) compared to CHF dogs with PNE < 600 pg/ml (0.32 +/- 0.08) (P < 0.01). Among CHF dogs, the MIT injury index was linearly related to PNE concentration (r = 0.57, P < 0.05), LV ejection fraction (r = 0.57, P < 0.05) and LV end-diastolic pressure (r = 0.57, P < 0.05). These data indicate that profound MIT abnormalities are present in the myocardium of dogs with CHF and are related to PNE concentration and to the severity of LV dysfunction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1479624     DOI: 10.1016/0022-2828(92)93098-5

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  53 in total

Review 1.  Mitochondria and heart failure: new insights into an energetic problem.

Authors:  L Chen; A A Knowlton
Journal:  Minerva Cardioangiol       Date:  2010-04       Impact factor: 1.347

Review 2.  Heart failure and loss of metabolic control.

Authors:  Zhao V Wang; Dan L Li; Joseph A Hill
Journal:  J Cardiovasc Pharmacol       Date:  2014-04       Impact factor: 3.105

3.  Cell death, tissue hypoxia and the progression of heart failure.

Authors:  H N Sabbah; V G Sharov; S Goldstein
Journal:  Heart Fail Rev       Date:  2000-06       Impact factor: 4.214

Review 4.  Left ventricular histomorphometric findings in dogs with heart failure treated with the Acorn Cardiac Support Device.

Authors:  Victor G Sharov; Anastassia V Todor; Hani N Sabbah
Journal:  Heart Fail Rev       Date:  2005-06       Impact factor: 4.214

Review 5.  Metabolic therapy for heart disease: impact of trimetazidine.

Authors:  Hani N Sabbah; William C Stanley
Journal:  Heart Fail Rev       Date:  2005-12       Impact factor: 4.214

Review 6.  New aspects of impaired mitochondrial function in heart failure.

Authors:  Mariana G Rosca; Charles L Hoppel
Journal:  J Bioenerg Biomembr       Date:  2009-04       Impact factor: 2.945

7.  Expression of cytoskeletal, linkage and extracellular proteins in failing dog myocardium.

Authors:  Victor G Sharov; Sawa Kostin; Anastassia Todor; Jutta Schaper; Hani N Sabbah
Journal:  Heart Fail Rev       Date:  2005-12       Impact factor: 4.214

8.  MicroRNA-15b modulates cellular ATP levels and degenerates mitochondria via Arl2 in neonatal rat cardiac myocytes.

Authors:  Hitoo Nishi; Koh Ono; Yoshitaka Iwanaga; Takahiro Horie; Kazuya Nagao; Genzou Takemura; Minako Kinoshita; Yasuhide Kuwabara; Rieko Takanabe Mori; Koji Hasegawa; Toru Kita; Takeshi Kimura
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

9.  Cyclosporine A attenuates mitochondrial permeability transition and improves mitochondrial respiratory function in cardiomyocytes isolated from dogs with heart failure.

Authors:  Victor G Sharov; Anastassia Todor; Sanjaya Khanal; Makoto Imai; Hani N Sabbah
Journal:  J Mol Cell Cardiol       Date:  2006-10-27       Impact factor: 5.000

Review 10.  Dynamic organization of mitochondria in human heart and in myocardial disease.

Authors:  Charles L Hoppel; Bernard Tandler; Hisashi Fujioka; Alessandro Riva
Journal:  Int J Biochem Cell Biol       Date:  2009-05-14       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.